These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Plasma level of macrophage-colony stimulating factor (M-CSF) in the course of breast cancer treatment].
    Author: Lawicki S, Omyła J, Mroczko B, Szmitkowski M, Czygier M.
    Journal: Pol Arch Med Wewn; 2004 Oct; 112(4):1181-7. PubMed ID: 15773430.
    Abstract:
    Macrophage-colony stimulating factor (M-CSF) is one of the glycoproteins called colony-stimulating factors (CSF). Some clinical investigations have shown an autologous production of M-CSF in various human cell lines in vitro and by tumour cells in vivo. We have investigated the plasma level of M-CSF and commonly accepted tumour marker, such as CA 15-3 in the plasma of 44 patients with breast cancer. Blood was taken before and in 30 and 180 days after surgery. The patients were divided into two groups: A (stage 1) and B (stage 11). M-CSF was determined using enzyme-linked immunosorbent assay (ELISA), CA 15-3 was measured by microparticle enzyme immunoassay (MEIA). M-CSF plasma levels were significantly higher in breast cancer patients before and after surgery comparing to the control group. The M-CSF level was higher in group B (11 stage) compared to the group A (I stage). These results suggest the potential role of M-CSF in the diagnostics and monitoring of breast cancer chemotherapy.
    [Abstract] [Full Text] [Related] [New Search]